M. Bertaux

Simultaneously acquired PET and ASL imaging biomarkers may be helpful in differentiating progression from pseudo-progression in treated gliomas

A. Pellerin, Maya Khalifé, Marc Sanson et al. · European Radiology · 2021 · 29 citations

Positron Emission Tomography, Neuro-oncology, Oncologic Imaging +13

Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study

M. Bertaux, Caroline Houillier, Véronique Edeline et al. · Journal of Neuro-Oncology · 2020 · 21 citations

Positron Emission Tomography, Neuro-oncology, Lymphoid Neoplasia +11

Can FDG-PET/MR help to overcome limitations of sequential MRI and PET-FDG for differential diagnosis between recurrence/progression and radionecrosis of high-grade gliomas?

Nadya Pyatigorskaya, B. Sgard, M. Bertaux et al. · Journal of Neuroradiology · 2020 · 19 citations

Positron Emission Tomography, Neuro-oncology, Medical Imaging +15

Prognostic value of one millisievert exercise myocardial perfusion imaging in patients without known coronary artery disease

Bernard Songy, Mohamed Guernou, D. Hivoux et al. · Journal of Nuclear Cardiology · 2016 · 14 citations

Health Sciences, Medical Imaging, Cardiovascular Disease +10

Delayed [18F]-FDG PET Imaging Increases Diagnostic Performance and Reproducibility to Differentiate Recurrence of Brain Metastases From Radionecrosis

H. Otman, J. Farce, Pierre Meneret et al. · Clinical Nuclear Medicine · 2022 · 13 citations · Full text